Advanced Microbiome Interventions (AMI) is a pharma biotech start-up that has been established in 2022. AMI is building on the founders’ inventions at Amsterdam University Medical Centre (AUMC) and Wageningen University, The Netherlands.

One of the first investments was received from the Innovation Fund Noord-Holland. Some of the foundational research has been published by the founders . All these content can be found elsewhere on this website under Press and Publications (link).